Abstract
The goal of the study was the assessment of heterogeneous platelet activation status in thrombus. In a ferric(III) chloride (FeCl3) thrombosis (intravital) model of C57BL/6 J mice, the area of irreversibly activated (phosphatidylserine (PS)-positive) platelets was assessed after 1-s exposure of a vessel to FeCl3. In a laser-induced thrombosis (intravital) model of GFP mice, the area of the thrombus composed of PS-negative platelets was evaluated. The ratio of the area of PECAM-1 to the area of the thrombus was used as a marker to assess the activity of PS-negative platelets. In the in vitro flow chamber model, the thrombus area (PS-negative and PS-positive platelets) and the platelet activation index (ratio of the area of PS-positive platelets to the area of thrombus) were determined. To assess platelet activation status with these models, acetylsalicylic acid (ASA) and iloprost (Ilo) were used. In the FeCl3 thrombosis, ASA (10 mg/kg, 100 mg/kg) decreased the area of PS-positive platelets. In the laser thrombosis, ASA (10 mg/kg) decreased the thrombus area, but the decrease in platelet activity was evident even at 3 mg/kg by an increased PECAM-1/thrombus ratio. In the flow chamber, ASA (0.02 mg/ml, 0.2 mg/ml) equally decreased the platelet activation index, whereas only at 0.2 mg/ml, it decreased the thrombus area. Ilo (3.6 ng/ml, 36 ng/ml) decreased the thrombus area but at 36 ng/ml increased the platelet activation index. We showed that intravital models and flow chamber provide a detailed assessment of platelet activation status and the mechanism of drug action.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aktas B, Pozgajova M, Bergmeier W, Sunnarborg S, Offermanns S, Lee D, Wagner DD, Nieswandt B (2005) Aspirin induces platelet receptor shedding via ADAM17 (TACE). J Biol Chem 280:39716–39722. https://doi.org/10.1074/jbc.M507762200
Armstrong PC, Kirkby NS, Zain ZN, Emerson M, Mitchell JA, Warner TD (2011) Thrombosis is reduced by inhibition of COX-1, but unaffected by inhibition of COX-2, in an acute model of platelet activation in the mouse. PLoS One 6:e20062. https://doi.org/10.1371/journal.pone.0020062
Armstrong RA, Lawrence RA, Jones RL, Wilson NH, Collier A (1989) Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors. Br J Pharmacol 97:657–668. https://doi.org/10.1111/j.1476-5381.1989.tb12001.x
Atkinson BT, Jasuja R, Chen VM, Nandivada P, Furie B, Furie BC (2010) Laser-induced endothelial cell activation supports fibrin formation. Blood 116:4675–4683. https://doi.org/10.1182/blood-2010-05-283986
Agbani EO, Cash J, Williams C, Poole A (2017) Phosphatidylserine exposure after vascular injury-platelet or endothelial. bioRxiv 115139. https://doi.org/10.1101/115139
Bevilacqua C, Finesso M, Prosdocimi M (1991) Acute carotid artery occlusive thrombosis and its pharmacological prevention in the rabbit. Thromb Res 62:263–273. https://doi.org/10.1016/0049-3848(91)90147-O
Brown M, Wittwer C (2000) Flow cytometry: principles and clinical applications in hematology. Clin Chem 46:1221–1229
Ciciliano JC, Sakurai Y, Myers DR, Fay ME, Hechler B, Meeks S, Li R, Dixon JB, Lyon LA, Gachet C, Lam WA (2015) Resolving the multifaceted mechanisms of the ferric chloride thrombosis model using an interdisciplinary microfluidic approach. Blood 126:817–824. https://doi.org/10.1182/blood-2015-02-628594
Colace TV, Muthard RW, Diamond SL (2012) Thrombus growth and embolism on tissue factor-bearing collagen surfaces under flow. Arterioscler Thromb Vasc Biol 32:1466–1476. https://doi.org/10.1161/ATVBAHA.112.249789
Cosemans JMEM, Angelillo-Scherrer A, Mattheij NJA, Heemskerk JWM (2013) The effects of arterial flow on platelet activation, thrombus growth, and stabilization. Cardiovasc Res 99:342–352. https://doi.org/10.1093/cvr/cvt110
Crochemore T, Piza FM d T, Rodrigues RDR, Guerra JC d C, Ferraz LJR, Corrêa TD (2017) A new era of thromboelastometry. Einstein (São Paulo) 15:380–385. https://doi.org/10.1590/s1679-45082017md3130
de Witt SM, Swieringa F, Cavill R, Lamers MME, van Kruchten R, Mastenbroek T, Baaten C, Coort S, Pugh N, Schulz A, Scharrer I, Jurk K, Zieger B, Clemetson KJ, Farndale RW, Heemskerk JWM, Cosemans JMEM (2014) Identification of platelet function defects by multi-parameter assessment of thrombus formation. Nat Commun 5:4257. https://doi.org/10.1038/ncomms5257
Doutremepuich C, Aguejouf O, Desplat V, Eizayaga FX (2012) Paradoxical effect of aspirin. Thrombosis 2012:1–4. https://doi.org/10.1155/2012/676237
Droebner K, Haasbach E, Dudek SE, Scheuch G, Nocker K, Canisius S, Ehrhardt C, von Degenfeld G, Ludwig S, Planz O (2017) Pharmacodynamics, pharmacokinetics, and antiviral activity of BAY 81-8781, a novel NF-κB inhibiting anti-influenza drug. Front Microbiol 8:2130. https://doi.org/10.3389/fmicb.2017.02130
El Haouari M, Bnouham M, Bendahou M, Aziz M, Ziyyat A, Legssyer A, Mekhfi H (2006) Inhibition of rat platelet aggregation by Urtica dioica leaves extracts. Phyther Res 20:568–572. https://doi.org/10.1002/ptr.1906
Falati S, Patil S, Gross PL, Stapleton M, Merrill-Skoloff G, Barrett NE, Pixton KL, Weiler H, Cooley B, Newman DK, Newman PJ, Furie BC, Furie B, Gibbins JM (2006) Platelet PECAM-1 inhibits thrombus formation in vivo. Blood 107:535–541. https://doi.org/10.1182/blood-2005-04-1512
Faraday N, Schunke K, Saleem S, Fu J, Wang B, Zhang J, Morrell C, Dore S (2013) Cathepsin G-dependent modulation of platelet thrombus formation in vivo by blood neutrophils. PLoS One 8:e71447. https://doi.org/10.1371/journal.pone.0071447
Fu CJ, Melethil S, Mason WD (1991) The pharmacokinetics of aspirin in rats and the effect of buffer. J Pharmacokinet Biopharm 19:157–173. https://doi.org/10.1007/BF01073867
Furie B, Furie BC (2007) In vivo thrombus formation. J Thromb Haemost 5:12–17. https://doi.org/10.1111/j.1538-7836.2007.02482.x
Giovanazzi S, Accomazzo MR, Letari O, Oliva D, Nicosia S (1997) Internalization and down-regulation of the prostacyclin receptor in human platelets. Biochem J 325:71–77. https://doi.org/10.1042/bj3250071
Gromotowicz-Poplawska A, Marcinczyk N, Misztal T, Golaszewska A, Aleksiejczuk M, Rusak T, Chabielska E (2019) Rapid effects of aldosterone on platelets, coagulation, and fibrinolysis lead to experimental thrombosis augmentation. Vasc Pharmacol 122–123:106598. https://doi.org/10.1016/j.vph.2019.106598
Hayashi T, Mogami H, Murakami Y, Nakamura T, Kanayama N, Konno H, Urano T (2008) Real-time analysis of platelet aggregation and procoagulant activity during thrombus formation in vivo. Pflugers Arch - Eur J Physiol 456:1239–1251. https://doi.org/10.1007/s00424-008-0466-9
Hildebrand M (1992) Pharmacokinetics of iloprost and cicaprost in mice. Prostaglandins 44:431–442
Jaschonek K, Faul C, Schmidt H, Renn W (1988) Desensitization of platelets to iloprost. Loss of specific binding sites and heterologous desensitization of adenylate cyclase. Eur J Pharmacol 147:187–196. https://doi.org/10.1016/0014-2999(88)90777-7
Jones CI, Garner SF, Moraes LA, Kaiser WJ, Rankin A, Ouwehand WH, Goodall AH, Gibbins JM (2009) PECAM-1 expression and activity negatively regulate multiple platelet signaling pathways. FEBS Lett 583:3618–3624. https://doi.org/10.1016/j.febslet.2009.10.037
Kawamura Y, Takahari Y, Tamura N, Eguchi Y, Urano T, Ishida H, Goto S (2010) Imaging of structural changes in endothelial cells and thrombus formation at the site of FeCl3-induced injuries in mice cremasteric arteries. J Atheroscler Thromb 16:807–814. https://doi.org/10.5551/jat.2030
Kovacs IB, Mayou SC, Kirby JD (1991) Infusion of a stable prostacyclin analogue, iloprost, to patients with peripheral vascular disease: lack of antiplatelet effect but risk of thromboembolism. Am J Med 90:41–46. https://doi.org/10.1016/0002-9343(91)90504-Q
Lee H, Sturgeon S, Mountford J, Jackson S, Hamilton J (2012) Safety and efficacy of targeting platelet proteinase-activated receptors in combination with existing anti-platelet drugs as antithrombotics in mice. Br J Pharmacol 166:2188–2197. https://doi.org/10.1111/j.1476-5381.2012.01944.x
Leszczyńska A, Misztal T, Marcińczyk N, Kamiński T, Kramkowski K, Chabielska E, Pawlak D (2019) Effect of quinolinic acid – a uremic toxin from tryptophan metabolism – on hemostatic profile in rat and mouse thrombosis models. Adv Med Sci 64:370–380. https://doi.org/10.1016/j.advms.2019.05.003
Lorrain J, Lechaire I, Gauffeny C, Masson R, Roome N, Herault J-P, O’Connor SE, Schaeffer P, Herbert J-M (2004) Effects of SanOrg123781A, a synthetic hexadecasaccharide, in a mouse model of electrically induced carotid artery injury: synergism with the antiplatelet agent clopidogrel. J Pharmacol Exp Ther 309:235–240. https://doi.org/10.1124/jpet.103.059873
Marcinczyk N, Jarmoc D, Leszczynska A, Zakrzeska A, Kramkowski K, Strawa J, Gromotowicz-Poplawska A, Chabielska E, Tomczyk M (2017) Antithrombotic potential of tormentil extract in animal models. Front Pharmacol 8:e534. https://doi.org/10.3389/fphar.2017.00534
Modesti PA, Fortini A, Poggesi L, Boddi M, Abbate R, Gensini GF (1987) Acute reversible reduction of PGI2 platelet receptors after iloprost infusion in man. Thromb Res 48:663–669. https://doi.org/10.1016/0049-3848(87)90432-4
Munnix ICA, Strehl A, Kuijpers MJE, Auger JM, van der Meijden PEJ, van Zandvoort MAM, Oude Egbrink MGA, Nieswandt B, Heemskerk JWM (2005) The glycoprotein VI-phospholipase Cγ2 signaling pathway controls thrombus formation induced by collagen and tissue factor in vitro and in vivo. Arterioscler Thromb Vasc Biol 25:2673–2678. https://doi.org/10.1161/01.ATV.0000193568.71980.4a
Nagelschmitz J, Blunck M, Kraetzschmar J, Ludwig M, Wensing G, Hohlfeld T (2014) Pharmacokinetics and pharmacodynamics of acetylsalicylic acid after intravenous and oral administration to healthy volunteers. Clin Pharm 6:51–59. https://doi.org/10.2147/CPAA.S47895
Peters RF, Lees CM, Mitchell KA, Tweed MF, Talbot MD, Wallis RB (1991) The characterisation of thrombus development in an improved model of arterio-venous shunt thrombosis in the rat and the effects of recombinant desulphatohirudin (CGP 39393), heparin, and iloprost. Thromb Haemost 65:268–274
Pluchart H, Khouri C, Blaise S, Roustit M, Cracowski JL (2017) Targeting the prostacyclin pathway: beyond pulmonary arterial hypertension. Trends Pharmacol Sci 38:512–523. https://doi.org/10.1016/j.tips.2017.03.003
Prakash P, Kulkarni PP, Lentz SR, Chauhan AK (2015) Cellular fibronectin containing extra domain a promotes arterial thrombosis in mice through platelet toll-like receptor 4. Blood 125:3164–3172. https://doi.org/10.1182/blood-2014-10-608653
Raber I, McCarthy CP, Vaduganathan M, Bhatt DL, Wood DA, Cleland JGF, Blumenthal RS, McEvoy JW (2019) The rise and fall of aspirin in the primary prevention of cardiovascular disease. Lancet (London, England) 393:2155–2167. https://doi.org/10.1016/S0140-6736(19)30541-0
Reddy EC, Wang H, Christensen H, McMillan-Ward E, Israels SJ, Bang KWA, Rand ML (2018) Analysis of procoagulant phosphatidylserine-exposing platelets by imaging flow cytometry. Res Pract Thromb Haemost 2:736–750. https://doi.org/10.1002/rth2.12144
Revenko AS, Gao D, Crosby JR, Bhattacharjee G, Zhao C, May C, Gailani D, Monia BP, MacLeod AR (2011) Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding. Blood 118:5302–5311. https://doi.org/10.1182/blood-2011-05-355248
Schmitt A, Guichard J, Massé JM, Debili N, Cramer EM (2001) Of mice and men: comparison of the ultrastructure of megakaryocytes and platelets. Exp Hematol 29:1295–1302. https://doi.org/10.1016/s0301-472x(01)00733-0
Shaw L-H, Tsai T-H (2012) Simultaneous determination and pharmacokinetics of protein unbound aspirin and salicylic acid in rat blood and brain by microdialysis: an application to herbal–drug interaction. J Chromatogr B 895–896:31–38. https://doi.org/10.1016/j.jchromb.2012.03.010
Singh J, Zeller W, Zhou N, Hategen G, Mishra R, Polozov A, Yu P, Onua E, Zhang J, Zembower D, Kiselyov A, Ramírez JL, Sigthorsson G, Bjornsson JM, Thorsteinsdottir M, Andrésson T, Bjarnadottir M, Magnusson O, Fabre J-E, Stefansson K, Gurney ME (2009) Antagonists of the EP 3 receptor for prostaglandin E 2 are novel antiplatelet agents that do not prolong bleeding. ACS Chem Biol 4:115–126. https://doi.org/10.1021/cb8002094
Stalker TJ, Traxler EA, Wu J, Wannemacher KM, Cermignano SL, Voronov R, Diamond SL, Brass LF (2013) Hierarchical organization in the hemostatic response and its relationship to the platelet-signaling network. Blood 15:526–537. https://doi.org/10.1182/blood-2012-09-457739
Strehl A, Munnix ICA, Kuijpers MJE, van der Meijden PEJ, Cosemans JMEM, Feijge MAH, Nieswandt B, Heemskerk JWM (2007) Dual role of platelet protein kinase C in thrombus formation. J Biol Chem 282:7046–7055. https://doi.org/10.1074/jbc.M611367200
Surin WR, Prakash P, Barthwal MK, Dikshit M (2010) Optimization of ferric chloride induced thrombosis model in rats: effect of anti-platelet and anti-coagulant drugs. J Pharmacol Toxicol Methods 61:287–291. https://doi.org/10.1016/j.vascn.2009.11.002
Van Kruchten R, Cosemans JMEM, Heemskerk JWM (2012) Measurement of whole blood thrombus formation using parallel-plate flow chambers – a practical guide. Platelets 23:229–242. https://doi.org/10.3109/09537104.2011.630848
Warner TD, Nylander S, Whatling C (2011) Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy. Br J Clin Pharmacol 72:619–633. https://doi.org/10.1111/j.1365-2125.2011.03943.x
Wientjes MG, Levy G (1988) Nonlinear pharmacokinetics of aspirin in rats. J Pharmacol Exp Ther 245:809–815
Witt W, Baldus B, Müller B (1987) Antithrombotic profile of iloprost in experimental models of arterial and venous thrombosis. In: Gryglewski RJ, Stock G (eds) Prostacyclin and its stable analogue Iloprost. Springer, Berlin Heidelberg, pp 81–90
Wojewodzka-Zelezniakowicz M, Kisiel W, Kramkowski K, Gromotowicz-Poplawska A, Zakrzeska A, Stankiewicz A, Kolodziejczyk P, Szemraj J, Ladny JR, Chabielska E (2016) Quinapril decreases antifibrinolytic and prooxidative potential of propofol in arterial thrombosis in hypertensive rats. J Renin-Angiotensin-Aldosterone Syst 17:1470320316647239. https://doi.org/10.1177/1470320316647239
Yakimenko AO, Verholomova FY, Kotova YN, Ataullakhanov FI, Panteleev MA (2012) Identification of different proaggregatory abilities of activated platelet subpopulations. Biophys J 102:2261–2269. https://doi.org/10.1016/j.bpj.2012.04.004
Zeymer U (2013) Oral antiplatelet therapy in acute coronary syndromes: recent developments. Cardiol Ther 2:47–56. https://doi.org/10.1007/s40119-013-0011-6
Zwaginga JJ, Nash G, King MR, Heemskerk JWM, Frojmovic M, Hoylaerts MF, Sakariassen KS (2006) Flow-based assays for global assessment of hemostasis. Part 1: biorheologic considerations. J Thromb Haemost 4:2486–2487. https://doi.org/10.1111/j.1538-7836.2006.02177.x
Funding
This work was supported by National Science Center, Poland (grant number: 2017/27/N/NZ7/02335) and Medical University of Bialystok (grant number: N/ST/MN/18/002/2226).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
Procedures involving animals and their care were conducted in conformity with the institutional guidelines that are in compliance with the national and international laws and Guidelines for the Use of Animals in Biomedical Research. All the procedures involving the animals and their care were approved by the Local Ethical Committee on Animal Testing at the Medical University of Bialystok (permit number: 73/2018).
Conflict of interest
All authors declare that they have no conflicts of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Marcinczyk, N., Golaszewska, A., Misztal, T. et al. New approaches for the assessment of platelet activation status in thrombus under flow condition using confocal microscopy. Naunyn-Schmiedeberg's Arch Pharmacol 393, 727–738 (2020). https://doi.org/10.1007/s00210-019-01789-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-019-01789-x